Home
About Us
Product Pipeline
Contact

Dermata

Home
About Us
Product Pipeline
Investors
Contact

Financial Results

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • Financial Info

  • Overview
  • Financial Results
  • Income Statement
  • Balance Sheet
  • Cash Flow

2023

Q1 2023

Quarter Ended Mar 31, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2022

FY 2022

Fiscal Year Ended Dec 31, 2022
Earnings Release
PDF HTML
10-K Filing
PDF HTML
10-K/A Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2022

Quarter Ended Sep 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2021

Quarter Ended Sep 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Contacts
  • RSS News Feed
Back to Top
Dermata Therapeutics, Inc.info@dermatarx.com